Skip to main content
Top
Published in: Annals of Hematology 8/2019

01-08-2019 | Skin Graft | Original Article

Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients

Authors: P. Lamby, D. Wolff, S. Mielke, G. U. Grigoleit, P. Ljungman, I. Hilgendorf, E. Holler, B. Holler, D. Weber, W. Herr, D. Schiltz, S. Klein, S. Graf, V. Bjornhagen-Safwenberg, J. Dolderer, L. Prantl

Published in: Annals of Hematology | Issue 8/2019

Login to get access

Abstract

Refractory skin ulcers due to severe chronic graft-versus-host disease (cGVHD) remain to be associated with significant morbidity and mortality.
We performed an allogeneic donor skin transplantation in seven adult patients after allogeneic hematopoietic stem cell transplantation for cGVHD-associated refractory skin ulcers. While four patients received a split skin graft (SSG), in one patient, a full thickness skin graft for two small refractory ulcers of the ankle was performed, and one patient received in vitro expanded donor keratinocyte grafts derived from hair roots of the original unrelated donor. In one additional patient, a large deep fascial defect of the lower leg was covered with an autologous greater omentum free graft before coverage with an allogeneic SSG. An additional patient was treated with an autologous scrotal skin graft for a refractory ulcer associated with deep sclerosis of cGVHD after unrelated donor transplantation.
All skin grafts engrafted and resulted in permanent coverage of the grafted ulcers without any signs of immunological mediated damage. In the patient receiving in vitro expanded keratinocyte grafts, two localized ulcers were permanently covered by donor skin while this approach failed to cover extensive circular ulcers of the lower legs.
Allogeneic donor skin grafts are a valuable treatment option in refractory ulcers due to cGVHD but are restricted mainly to related donors while keratinocyte grafts from unrelated donors remain experimental. In male patients lacking a related donor, autologous scrotal skin graft may be an alternative option.
Appendix
Available only for authorised users
Literature
2.
go back to reference Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy P, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ, Graft-vs-Host Disease Working Committee of the CIBMTR (2015) Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 21:266–274CrossRefPubMed Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, Urbano-Ispizua A, Cutler CS, Bacigalupo AA, Battiwalla M, Flowers ME, Juckett MB, Lee SJ, Loren AW, Klumpp TR, Prockup SE, Ringdén OT, Savani BN, Socié G, Schultz KR, Spitzer T, Teshima T, Bredeson CN, Jacobsohn DA, Hayashi RJ, Drobyski WR, Frangoul HA, Akpek G, Ho VT, Lewis VA, Gale RP, Koreth J, Chao NJ, Aljurf MD, Cooper BW, Laughlin MJ, Hsu JW, Hematti P, Verdonck LF, Solh MM, Norkin M, Reddy V, Martino R, Gadalla S, Goldberg JD, McCarthy P, Pérez-Simón JA, Khera N, Lewis ID, Atsuta Y, Olsson RF, Saber W, Waller EK, Blaise D, Pidala JA, Martin PJ, Satwani P, Bornhäuser M, Inamoto Y, Weisdorf DJ, Horowitz MM, Pavletic SZ, Graft-vs-Host Disease Working Committee of the CIBMTR (2015) Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 21:266–274CrossRefPubMed
3.
go back to reference Grube M, Holler E, Weber D, Holler B, Herr W, Wolff D (2016) Risk factors and outcome of chronic graft-versus-host disease after allogeneic stem cell transplantation-results from a single-center observational study. Biol Blood Marrow Transplant 22:1781–1791CrossRefPubMed Grube M, Holler E, Weber D, Holler B, Herr W, Wolff D (2016) Risk factors and outcome of chronic graft-versus-host disease after allogeneic stem cell transplantation-results from a single-center observational study. Biol Blood Marrow Transplant 22:1781–1791CrossRefPubMed
4.
go back to reference Marks C, Stadler M, Hausermann P et al (2011) German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD. Br J Dermatol 165:18–29CrossRefPubMed Marks C, Stadler M, Hausermann P et al (2011) German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD. Br J Dermatol 165:18–29CrossRefPubMed
5.
go back to reference Inamoto Y, Storer BE, Petersdorf EW, Nelson JL, Lee SJ, Carpenter PA, Sandmaier BM, Hansen JA, Martin PJ, Flowers MED (2013) Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. Blood 121:5098–5103CrossRefPubMedPubMedCentral Inamoto Y, Storer BE, Petersdorf EW, Nelson JL, Lee SJ, Carpenter PA, Sandmaier BM, Hansen JA, Martin PJ, Flowers MED (2013) Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. Blood 121:5098–5103CrossRefPubMedPubMedCentral
7.
go back to reference Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ (2005) Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 105:3802–3811CrossRefPubMedPubMedCentral Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ (2005) Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood 105:3802–3811CrossRefPubMedPubMedCentral
8.
go back to reference Amendola F, Gazzola R, Lombardo M, Caminiti R, Dagna L, Baruffaldi-Preis FW (2016) Chronic ulcer by cutaneous GvHD after bone marrow transplantation treated with skin allograft from HLA-identical donor: case report and literature review. Int J Low Extrem Wounds 15:139–141CrossRefPubMed Amendola F, Gazzola R, Lombardo M, Caminiti R, Dagna L, Baruffaldi-Preis FW (2016) Chronic ulcer by cutaneous GvHD after bone marrow transplantation treated with skin allograft from HLA-identical donor: case report and literature review. Int J Low Extrem Wounds 15:139–141CrossRefPubMed
9.
go back to reference Ammer J, Prantl L, Holler B, Landfried K, Wolff D, Karrer S, Andreesen R, Holler E (2012) Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor. Bone Marrow Transplant 47:1368–1369CrossRefPubMed Ammer J, Prantl L, Holler B, Landfried K, Wolff D, Karrer S, Andreesen R, Holler E (2012) Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor. Bone Marrow Transplant 47:1368–1369CrossRefPubMed
10.
go back to reference Baumeister RG, Riel KA, Kolb HJ (1990) Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 61:438–440PubMed Baumeister RG, Riel KA, Kolb HJ (1990) Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 61:438–440PubMed
11.
go back to reference Crocchiolo R, Nicolini FE, Sobh M, Ducastelle-Lepretre S, Labussiere H, Dubois V, Auxenfans C, Mojallal A, Damour O, Braye F, Michallet M (2011) Treatment of a severe extensive cutaneous chronic GVHD after allo-HSCT using glycerolyzed skin allografts and cultured epidermis from the same donor. Bone Marrow Transplant 46:1153–1155CrossRefPubMed Crocchiolo R, Nicolini FE, Sobh M, Ducastelle-Lepretre S, Labussiere H, Dubois V, Auxenfans C, Mojallal A, Damour O, Braye F, Michallet M (2011) Treatment of a severe extensive cutaneous chronic GVHD after allo-HSCT using glycerolyzed skin allografts and cultured epidermis from the same donor. Bone Marrow Transplant 46:1153–1155CrossRefPubMed
12.
go back to reference Knobler HY, Sagher U, Peled IJ et al (1985) Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor. Transplantation 40:223–225CrossRefPubMed Knobler HY, Sagher U, Peled IJ et al (1985) Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor. Transplantation 40:223–225CrossRefPubMed
13.
go back to reference Kondo S, Tamura K, Makino S, Takamatsu Y (1994) Allogeneic skin grafting for extensive skin chronic graft-versus-host disease. Int J Hematol 60:151–155PubMed Kondo S, Tamura K, Makino S, Takamatsu Y (1994) Allogeneic skin grafting for extensive skin chronic graft-versus-host disease. Int J Hematol 60:151–155PubMed
14.
go back to reference Tausche AK, Skaria M, Bohlen L, Liebold K, Hafner J, Friedlein H, Meurer M, Goedkoop RJ, Wollina U, Salomon D, Hunziker T (2003) An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers. Wound Repair Regen 11:248–252CrossRefPubMed Tausche AK, Skaria M, Bohlen L, Liebold K, Hafner J, Friedlein H, Meurer M, Goedkoop RJ, Wollina U, Salomon D, Hunziker T (2003) An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers. Wound Repair Regen 11:248–252CrossRefPubMed
15.
go back to reference Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, van den Brink MRM, Hansen JA, Parkman R, Miklos DB, Martin PJ, Paczesny S, Vogelsang G, Pavletic S, Ritz J, Schultz KR, Blazar BR (2017) The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Biol Blood Marrow Transplant 23:211–234CrossRefPubMed Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, van den Brink MRM, Hansen JA, Parkman R, Miklos DB, Martin PJ, Paczesny S, Vogelsang G, Pavletic S, Ritz J, Schultz KR, Blazar BR (2017) The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Biol Blood Marrow Transplant 23:211–234CrossRefPubMed
16.
go back to reference Biedermann BC (2008) Vascular endothelium and graft-versus-host disease. Best Pract Res Clin Haematol 21:129–138CrossRefPubMed Biedermann BC (2008) Vascular endothelium and graft-versus-host disease. Best Pract Res Clin Haematol 21:129–138CrossRefPubMed
17.
go back to reference Croudace JE, Inman CF, Abbotts BE, Nagra S, Nunnick J, Mahendra P, Craddock C, Malladi R, Moss PAH (2012) Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD. Blood 120:4246–4255CrossRefPubMed Croudace JE, Inman CF, Abbotts BE, Nagra S, Nunnick J, Mahendra P, Craddock C, Malladi R, Moss PAH (2012) Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD. Blood 120:4246–4255CrossRefPubMed
18.
go back to reference Martires KJ, Baird K, Citrin DE, Hakim FT, Pavletic SZ, Cowen EW (2011) Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses. Arch Dermatol 147:1081–1086CrossRefPubMed Martires KJ, Baird K, Citrin DE, Hakim FT, Pavletic SZ, Cowen EW (2011) Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses. Arch Dermatol 147:1081–1086CrossRefPubMed
20.
go back to reference Berg JO, Vindelov L, Schmidt G, Drzewiecki KT (2008) Allogeneic split-skin grafting in stem cell transplanted patients. J Plastic Reconstr Aesthet Surg 61:1512–1515CrossRef Berg JO, Vindelov L, Schmidt G, Drzewiecki KT (2008) Allogeneic split-skin grafting in stem cell transplanted patients. J Plastic Reconstr Aesthet Surg 61:1512–1515CrossRef
21.
go back to reference Saltz R (1995) Endoscopic harvest of the omental and jejunal free flaps. Clin Plast Surg 22:747–754PubMed Saltz R (1995) Endoscopic harvest of the omental and jejunal free flaps. Clin Plast Surg 22:747–754PubMed
22.
go back to reference Maloney CT Jr, Wages D, Upton J, Lee WP (2003) Free omental tissue transfer for extremity coverage and revascularization. Plast Reconstr Surg 111:1899–1904CrossRefPubMed Maloney CT Jr, Wages D, Upton J, Lee WP (2003) Free omental tissue transfer for extremity coverage and revascularization. Plast Reconstr Surg 111:1899–1904CrossRefPubMed
23.
go back to reference MacNeil S (2008) Biomaterials for tissue engineering of skin. materialstoday 11:26–35 MacNeil S (2008) Biomaterials for tissue engineering of skin. materialstoday 11:26–35
24.
go back to reference Zeiser R, Blazar BR (2017) Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med 377:2565–2579CrossRefPubMed Zeiser R, Blazar BR (2017) Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med 377:2565–2579CrossRefPubMed
25.
go back to reference Falanga V, Sabolinski M (1999) A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 7:201–207CrossRefPubMed Falanga V, Sabolinski M (1999) A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 7:201–207CrossRefPubMed
Metadata
Title
Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients
Authors
P. Lamby
D. Wolff
S. Mielke
G. U. Grigoleit
P. Ljungman
I. Hilgendorf
E. Holler
B. Holler
D. Weber
W. Herr
D. Schiltz
S. Klein
S. Graf
V. Bjornhagen-Safwenberg
J. Dolderer
L. Prantl
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 8/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-019-03687-x

Other articles of this Issue 8/2019

Annals of Hematology 8/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.